Cationic liposomes with plasmid DNA influence cancer metastatic capability

Anticancer Research

Volumn 22, Issue 6 C, 2002, Pages 4049-4052

  Ota, Takahide ^a   Maeda, Masayo ^a   Tatsuka, Masaaki ^b  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Cancer metastasis; Gene therapy; Gene transfer; Lipofection; Side effects

Indexed keywords

CELLFECTIN; EFFECTENE; LIPOFECTAMINE; LIPOFECTIN; LIPOSOME; NILVADIPINE; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL FUNCTION; COMPLEX FORMATION; CONTROLLED STUDY; DNA TRANSFECTION; DNA TRANSFER; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; GENE TARGETING; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

3T3 CELLS; ANIMALS; CARCINOMA, LEWIS LUNG; CATION EXCHANGE RESINS; CATIONS; CELL LINE, TRANSFORMED; DNA; GENE THERAPY; LIPIDS; LIPOSOMES; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; PHOSPHATIDYLETHANOLAMINES; PLASMIDS; TUMOR CELLS, CULTURED;

EID: 0036875329     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Colosimo A, Goncz KK, Holmes AR, Kunzelmann K, Novelli G, Malone RW, Bennett MJ and Gruenert DC: Transfer and expression of foreign genes in mammalian cells. BioTechniques 29: 314-324, 2000.
2. Drummond DC, Meyer O, Hong K, Kirpotin DB and Papahadjopoulos D: Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 51: 691-743, 1999.
3. Hodgson CP and Solaiman F: Virosomes: cationic liposomes enhance retroviral transduction. Nat Biotechnol 14: 339-342, 1996.
4. Langner M and Kral TE: Liposome-based drug delivery systems. Pol J Pharmacol 51: 211-222, 1999.
5. Katsel PL and Greenstein RJ: Eukaryotic gene transfer with liposomes: effect of differences in lipid structure. Biotechnol Annu Rev 5: 197-220, 2000.
6. Mahato RI, Rolland A and Tomlinson E: Cationic lipid-based gene delivery systems: pharmaceutical perspectives. Pharm Res 14: 853-859, 1997.
7. Hofland H and Huang L: Inhibition of human ovarian carcinome cell proliferation by liposome-plasmid DNA complex. Biochem Biophys Res Commun 207: 492-496, 1995.
8. Tatsuka M, Ota T, Yamagishi N, Kashihara Y, Wada M, Matsuda N, Mitsui H, Seiki M and Odashima S: Different metastatic potentials of ras- and src-transformed BALB/c 3T3 A31 variant cells. Mol Carcinog 15: 300-308, 1996.
9. Tatsuka M, Ota T, Maeda M, Wada M, Yamagishi N, Taniguchi S, Seiki M and Odashima S: A BALB/c 3T3-transformed cell line suitable for transfection assay of metastasis-inducing genes. Int J Cancer 71: 88-93, 1997.
10. Kakunaga T and Crow JD: Cell variants showing differential susceptibility to ultraviolet light-induced transformation. Science 209: 505-507, 1980.
11. Hart IR: The selection and characterization of an invasive variant of the B16 melanoma. Am J Pathol 97: 587-600, 1979.
12. Ota T, Maeda M, Tatsuka M, Matsui T, Tanino M and Tanaka T: Decrease of metastatic ability after selection for intravasating ability in Lewis lung carcinoma (3LL) cell line. Cancer Lett 139: 105-108, 1999.
13. Terada Y, Tatsuka M, Jinno S and Okayama H: Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet irradiation. Nature 376: 358-362, 1995.
14. Wexler H: Accurate identification of experimental pulmonary metastases. J Natl Cancer Inst 36: 641-645, 1966.